KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares Repurchased
Ratios

Fulgent Genetics (FLGT) Receivables - Net (2016 - 2025)

Fulgent Genetics' Receivables - Net history spans 10 years, with the latest figure at $84.8 million for Q4 2025.

  • For Q4 2025, Receivables - Net rose 22.81% year-over-year to $84.8 million; the TTM value through Dec 2025 reached $84.8 million, up 22.81%, while the annual FY2025 figure was $84.8 million, 22.81% up from the prior year.
  • Receivables - Net for Q4 2025 was $84.8 million at Fulgent Genetics, up from $71.2 million in the prior quarter.
  • Across five years, Receivables - Net topped out at $216.5 million in Q1 2021 and bottomed at $34.8 million in Q2 2023.
  • The 5-year median for Receivables - Net is $71.3 million (2025), against an average of $89.7 million.
  • The largest annual shift saw Receivables - Net skyrocketed 3298.35% in 2021 before it tumbled 73.89% in 2023.
  • A 5-year view of Receivables - Net shows it stood at $138.9 million in 2021, then tumbled by 62.03% to $52.7 million in 2022, then decreased by 3.07% to $51.1 million in 2023, then surged by 34.99% to $69.0 million in 2024, then increased by 22.81% to $84.8 million in 2025.
  • Per Business Quant, the three most recent readings for FLGT's Receivables - Net are $84.8 million (Q4 2025), $71.2 million (Q3 2025), and $77.2 million (Q2 2025).